Lymphocyte Count at 4 Days Postoperatively and CRP Level at 7 Days Postoperatively: Reliable and Useful Markers for Surgical Site Infection Following Instrumented Spinal Fusion

Spine
Eiichiro IwataYasuhito Tanaka

Abstract

A case-control study. The objective of this study is to identify biochemical markers for surgical site infection (SSI) in posterior instrumented spinal fusion that are not affected by operative circumstances and to determine diagnostic cutoffs for these markers. Numerous biochemical markers may be used for early detection of SSI; however, these markers may be affected by operative factors. We reviewed data on C-reactive protein level and total white blood cell count and differential count before instrumented spinal fusion and at 1, 4, and 7 days postoperatively. The 141 patients in our sample were divided into an SSI group (patients who developed deep SSI) and a no-SSI group. We determined which markers differed significantly between groups and identified those not affected by operative circumstances (operating time, intraoperative blood loss, number of fusion segments) in the no-SSI group. Then, we determined diagnostic cutoffs for these unaffected markers by using receiver-operating characteristic curves. Three markers were selected: lymphocyte count at 4 days postoperatively (cutoff 1180/μL, sensitivity 90.9%, specificity 65.4%, area under the curve [AUC] 0.80), lymphocyte count of at 7 days postoperatively (cutoff <1090/μL,...Continue Reading

References

Sep 1, 1991·Spine·B JönssonB Strömqvist
Jul 1, 1996·Critical Care Medicine·R C Bone
Jun 1, 1997·Journal of Neurosurgery·A D LeviV K Sonntag
Apr 29, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·A J MangramW R Jarvis
Aug 15, 2002·Journal of Spinal Disorders & Techniques·Jun TakahashiKunio Takaoka
Jun 17, 2005·Spine·Andrew FangDavid S Bradford
Nov 14, 2007·The Journal of Bone and Joint Surgery. British Volume·H AonoM Iwasaki
Dec 14, 2007·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Iona CollinsJeremy Fairbank
Jan 4, 2008·The Journal of Bone and Joint Surgery. American Volume·Margaret A OlsenVictoria J Fraser
May 7, 2010·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·J J P SchimmelJ van Limbeek
Jun 11, 2011·Acta Orthopaedica·Clayton N KraftPeter H Pennekamp
Jan 6, 2012·International Orthopaedics·Antoine GeromettaFabian Bitan
Aug 28, 2012·Journal of Neurosurgery. Spine·Steven M KurtzSteven Glassman
Jan 18, 2014·Global Spine Journal·Masayoshi IshiiKazutaka Izawa

❮ Previous
Next ❯

Citations

Oct 30, 2020·Acta neurochirurgica·Markus LenskiSebastian Siller
May 6, 2021·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Hideaki ImabayashiKazuhiro Chiba
May 30, 2021·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Hideaki ImabayashiKazuhiro Chiba
Aug 5, 2021·Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders·Hiroaki KijimaYoichi Shimada

❮ Previous
Next ❯

Methods Mentioned

BETA
ESR

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
Takahiro MakinoKazuo Yonenobu
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Luis García de Guadiana-RomualdoMaría Dolores Albaladejo-Otón
© 2022 Meta ULC. All rights reserved